Chromothripsis in acute myeloid leukemia: biological features and impact on survivalMaria Chiara Fontana, Giovanni Martinelli, Giovanni Marconi et al.|Leukemia|2018Cited by 115
Constitutive activation of the DNA damage response pathway as a novel therapeutic target in diffuse large B-cell lymphomaEnrico Derenzini, Pier Luigi Zinzani, Claudio Agostinelli et al.|Oncotarget|2015Cited by 59
Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemiaAndrea Ghelli Luserna di Rorà, Giovanni Martinelli, Neil Beeharry et al.|Journal of Hematology & Oncology|2018Cited by 56
Prexasertib, a Chk1/Chk2 inhibitor, increases the effectiveness of conventional therapy in B-/T- cell progenitor acute lymphoblastic leukemiaAndrea Ghelli Luserna di Rorà, Giovanni Martinelli, Ilaria Iacobucci et al.|Oncotarget|2016Cited by 42
Integrated genomic-metabolic classification of acute myeloid leukemia defines a subgroup with NPM1 and cohesin/DNA damage mutationsGiorgia Simonetti, Giovanni Martinelli, Carlo Mengucci et al.|Leukemia|2021Cited by 37